Bard Updates Financial Community On Progress of EndoCinch.Business Editors/Health & Medical Writers MURRAY HILL, N.J.--(BW HealthWire)--Oct. 24, 2000 C. R. Bard C. R. Bard, Inc. (NYSE: BCR) is one of the large S&P 500 companies of the United States, a surgical specialties and hospital medical device manufacturer in Murray Hill, New Jersey. It is named after its founder, who sold the company within only a few years of its founding. , Inc. (NYSE-BCR) today announced that Bard Chairman and Chief Executive Officer, William H. Longfield, in prepared remarks at the CIBC CIBC Canadian Imperial Bank of Commerce CIBC Centres Interinstitutionnels de Bilan de Compétences CIBC Commonwealth Institute of Biological Control (Trinidad) CIBC Commercial International Brokerage Company healthcare conference in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , reviewed the progress of Bard's new product to treat GERD GERD gastroesophageal reflux disease. GERD abbr. gastroesophageal reflux disease GERD (gastroesophageal reflux disease gastroesophageal reflux disease (GERD) Disorder characterized by frequent passage of gastric contents from the stomach back into the esophagus. Symptoms of GERD may include heartburn, coughing, frequent clearing of the throat, and difficulty in swallowing. ). Over 240 patients have been treated with the Bard(R) EndoCinch(TM) suturing system since it received Food and Drug Administration clearance in late March 2000. The majority of patients treated with the EndoCinch procedure require only mild sedation for the procedure and are able to return home the same day. The EndoCinch device is used to treat symptomatic GERD. GERD is a chronic digestive condition in which stomach acid backs up into the esophagus, causing severe heartburn. Prolonged exposure to stomach acid can lead to ulcers, asthma and the development of esophageal cancer. This product provides a breakthrough therapy and complements Bard's complete line of minimally invasive diagnostic and therapeutic products used with flexible endoscopy endoscopy Examination of the body's interior through an instrument inserted into a natural opening or an incision, usually as an outpatient procedure. Endoscopes include the upper gastrointestinal endoscope (for the esophagus, stomach, and duodenum), the colonoscope (for the in gastroenterology. The company plans to have 100 active centers performing EndoCinch procedures by year end. Also, during the financial portion of the presentation, Bard estimated that Fourth Quarter 2000 sales revenue would grow at approximately 6 percent, including a 2 percent negative impact from foreign currency translation. C. R. Bard, Inc., (www.crbard.com) headquartered in Murray Hill, New Jersey
This press release contains forward-looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Please refer to our June 30, 2000 Form 10-Q for a statement with regard to forward-looking statements, including disclosure of the factors that could cause actual results to differ materially from those expressed or implied. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion